Form 4: Scientific Industries Director Blechman Acquires Shares and Warrants
SEC Form 4 Filing
Director Michael Blechman purchased 10,000 shares of Scientific Industries and warrants to acquire an additional 10,000 shares on April 18, 2025.
Summary
- On April 18, 2025, Michael Blechman, a director of Scientific Industries Inc., acquired 10,000 shares of common stock.
- Blechman also acquired warrants to purchase an additional 10,000 shares of common stock.
- The purchase price for the shares and warrants was $10,000.
- The exercise price for the warrants is $1.00 per share.
- Following the transaction, Blechman beneficially owns 47,186 shares of Scientific Industries Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares and warrants suggests confidence, but it's a relatively small transaction.
Positives
- A director's purchase of company stock and warrants can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This transaction is a routine disclosure of insider trading activity. It is common for directors and officers of publicly traded companies to buy and sell shares of their company's stock. These transactions are regulated by the SEC and must be disclosed to the public.
Stakeholder Impact
- The purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 04/18/2025 | Date of transaction: Purchase of shares and warrants. |
| 05/19/2025 | Date of Form 4 filing. |
| 10/18/2025 | Expiration date of the warrants. |
Keywords
Form 4, Director, Michael Blechman, SCND, Scientific Industries Inc, Share Purchase, Warrants, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.